Biliary metabolites of all-trans-retinoic acid in the rat☆
References (18)
- et al.
J. Nutr
(1968) - et al.
J. Lipid Res
(1966) - et al.
Biochem. Pharmacol
(1981) - et al.
Arch. Biochem. Biophys
(1981) - et al.
J. Biol. Chem
(1982) - et al.
J. Nutr
(1963) - et al.
J. Biol. Chem
(1982) - et al.
J. Biol. Chem
(1979) - et al.
Arch. Biochem. Biophys
(1980)
Cited by (21)
Fat-soluble vitamin and phytochemical metabolites: Production, gastrointestinal absorption, and health effects
2023, Progress in Lipid ResearchNutritional Diseases
2019, Mader's Reptile and Amphibian Medicine and SurgeryIn vivo pharmacokinetics and biodistribution of novel all-trans retinoic acid derivative-loaded, folate-modified poly (L-amino acid) micelles
2017, Journal of Drug Delivery Science and TechnologyCitation Excerpt :As for the observed dual peak phenomenon, we suggest enterohepatic cycling as a suitable explanation. Because all-trans retinoic acid (ATRA), the parent compound, is reported to have approximately 60% of the administered dose in bile [32], it is reasonable to hypothesize that ATPR follows a similar absorption pattern. This would lead to an influx of ATPR in bile and subsequent reabsorption into the bloodstream, accounting for the second peak.
Vitamin A Metabolism in the Fetus and Neonate
2017, Fetal and Neonatal Physiology, 2-Volume SetRetinoid Structure, Chemistry, and Biologically Active Derivatives
1997, Advances in Organ BiologyChromatography of retinoids
1990, Journal of Chromatography B: Biomedical Sciences and Applications
- ☆
This work was supported by program project Grant AM-14881 from the National Institutes of Health, a predoctoral fellowship from Procter and Gamble, and by the Harry Steenbock Research Fund of the Wisconsin Alumni Research Foundation.
- 2
Present address: Procter and Gamble Co., Research and Development Department, Miami Valley Laboratories, P.O. Box 39175, Cincinnati, Ohio 45247.